Yanjia Chen

745 total citations · 1 hit paper
7 papers, 320 citations indexed

About

Yanjia Chen is a scholar working on Infectious Diseases, Molecular Biology and Animal Science and Zoology. According to data from OpenAlex, Yanjia Chen has authored 7 papers receiving a total of 320 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 3 papers in Molecular Biology and 3 papers in Animal Science and Zoology. Recurrent topics in Yanjia Chen's work include SARS-CoV-2 and COVID-19 Research (6 papers), Animal Virus Infections Studies (3 papers) and Bacillus and Francisella bacterial research (2 papers). Yanjia Chen is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (6 papers), Animal Virus Infections Studies (3 papers) and Bacillus and Francisella bacterial research (2 papers). Yanjia Chen collaborates with scholars based in China and United States. Yanjia Chen's co-authors include Xiaoyu Zhao, Pengfei Wang, Huanzhang Zhu, Shibo Jiang, Hao Zhou, Rui Qiao, Yuchen Cui, Wenhong Zhang, Lulu Yang and Xun Wang and has published in prestigious journals such as Nature reviews. Immunology, Cell Host & Microbe and Virology.

In The Last Decade

Yanjia Chen

7 papers receiving 317 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Broadly neutralizing antibodies to SARS-CoV-2 and other human coronaviruses

2022 195 citations Yanjia Chen, Xiaoyu Zhao et al. Nature reviews. Immunology profile →

Peers

Countries citing papers authored by Yanjia Chen

Since Specialization

Citations

This map shows the geographic impact of Yanjia Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanjia Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanjia Chen more than expected).

Fields of papers citing papers by Yanjia Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanjia Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanjia Chen. The network helps show where Yanjia Chen may publish in the future.

Co-authorship network of co-authors of Yanjia Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Yanjia Chen. A scholar is included among the top collaborators of Yanjia Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanjia Chen. Yanjia Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

#	Work	Indexed citations
1	Longitudinal Analysis of Humoral and Cellular Immune Response up to 6 Months after SARS-CoV-2 BA.5/BF.7/XBB Breakthrough Infection and BA.5/BF.7-XBB Reinfection 2024 ·Vaccines ·Xun Wang, (unknown), Kaifeng Wei, Chen Li, (unknown), Shujun Jiang, (unknown), Xiaoyu Zhao, Rui Qiao, Yuchen Cui, Yanjia Chen, Jiayan Li, (unknown), Changyi Liu, (unknown), Wenhong Zhang, (unknown), Pengfei Wang, (unknown)	4
2	Broad‐spectrum coronavirus neutralization induced by hetero RBD‐Fc protein vaccine 2024 ·Journal of Medical Virology ·(unknown), (unknown), Shuai Jiang, (unknown), Chen Li, Xinyu Liu, Rui Qiao, Xiaoyu Zhao, Yuchen Cui, Yanjia Chen, Jiayan Li, Changyi Liu, (unknown), (unknown), Pengfei Wang	2
3	In Vitro Antibody-Dependent Enhancement of SARS-CoV-2 Infection Could Be Abolished by Adding Human IgG 2023 ·Pathogens ·Xun Wang, Minghui Li, Panpan Lu, Chen Li, (unknown), Xiaoyu Zhao, Rui Qiao, Yuchen Cui, Yanjia Chen, Jiayan Li, (unknown), Pengfei Wang	1
4	Structure-based virtual screening of ROCK1 inhibitors for the discovery of Enterovirus-A71 antivirals 2023 ·Virology ·Rui Qiao, (unknown), Jiayan Li, (unknown), (unknown), (unknown), Minghui Li, Yuchen Cui, Yanjia Chen, (unknown), Qingyu Wu, Xiaoyu Zhao, (unknown)	4
5	Antibody evasion of SARS-CoV-2 Omicron BA.1, BA.1.1, BA.2, and BA.3 sub-lineages 2022 ·Cell Host & Microbe ·Jingwen Ai, Xun Wang, Xinyi He, Xiaoyu Zhao, Yi Zhang, Yuchao Jiang, Minghui Li, Yuchen Cui, Yanjia Chen, Rui Qiao, Lin Li, Lulu Yang, Yi Li, Zixin Hu, Wenhong Zhang, Pengfei Wang	113
6	Broadly neutralizing antibodies to SARS-CoV-2 and other human coronaviruses breakdown → 2022 ·Nature reviews. Immunology ·Yanjia Chen, Xiaoyu Zhao, Hao Zhou, Huanzhang Zhu, Shibo Jiang, Pengfei Wang	195
7	Antibody Resistance of SARS-CoV-2 Omicron BA.1, BA.1.1, BA.2 and BA.3 Sub-Lineages 2022 ·SSRN Electronic Journal ·(unknown), Xun Wang, Xinyi He, Xiaoyu Zhao, Yi Zhang, Yuchao Jiang, Minghui Li, Yuchen Cui, Yanjia Chen, Rui Qiao, Lin Li, Lulu Yang, Yi Li, Zixin Hu, Wenhong Zhang, Pengfei Wang	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact